Cargando…
Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines
The existence of pathogens that escape recognition by specific vaccines, the need to improve existing vaccines and the increased availability of therapeutic (non-infectious disease) vaccines necessitate the rational development of novel vaccine concepts based on the induction of protective cell-medi...
Autores principales: | Savelkoul, Huub F. J., Ferro, Valerie A., Strioga, Marius M., Schijns, Virgil E. J. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494243/ https://www.ncbi.nlm.nih.gov/pubmed/26344951 http://dx.doi.org/10.3390/vaccines3010148 |
Ejemplares similares
-
Mucosal Immune Development in Early Life: Setting the Stage
por: Brugman, Sylvia, et al.
Publicado: (2015) -
Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants
por: Anggraeni, Rahmi, et al.
Publicado: (2022) -
Mucosal vaccine adjuvants update
por: Rhee, Joon Haeng, et al.
Publicado: (2012) -
Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation
por: Schijns, Virgil, et al.
Publicado: (2021) -
Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations
por: Pérez, O., et al.
Publicado: (2012)